I spent decades pleasing everyone. Then cancer changed the equation.
I spent decades pleasing everyone. Then cancer changed the equation.
Last updated: 2026-08-20 11:32:02 ET
I spent decades pleasing everyone. Then cancer changed the equation.
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win for mRNA vaccines ag...
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, joins "The Takeout" to discuss the Trump administration's touting of l...
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
A 39-year-old fitness coach mistook her colon cancer symptoms for IBS
The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
It's the data, stupid.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE